CytA, a reductase in the cytorhodin biosynthesis pathway, inactivates anthracycline drugs in Streptomyces

[1]  B. Philmus,et al.  Self-Resistance of Natural Product Producers: Past, Present, and Future Focusing on Self-Resistant Protein Variants. , 2018, ACS chemical biology.

[2]  Yucheng Gu,et al.  Elucidating the Sugar Tailoring Steps in the Cytorhodin Biosynthetic Pathway. , 2017, Organic letters.

[3]  Charles B. Larson,et al.  PCR-Independent Method of Transformation-Associated Recombination Reveals the Cosmomycin Biosynthetic Gene Cluster in an Ocean Streptomycete. , 2017, Journal of natural products.

[4]  D. Yellon,et al.  Anthracycline Chemotherapy and Cardiotoxicity , 2017, Cardiovascular Drugs and Therapy.

[5]  Qiang Zhou,et al.  Hydroxyl regioisomerization of anthracycline catalyzed by a four-enzyme cascade , 2017, Proceedings of the National Academy of Sciences.

[6]  J. Ju,et al.  Discovery of a new family of Dieckmann cyclases essential to tetramic acid and pyridone-based natural products biosynthesis. , 2015, Organic letters.

[7]  Bradley S Moore,et al.  Glycogenomics as a mass spectrometry-guided genome-mining method for microbial glycosylated molecules , 2013, Proceedings of the National Academy of Sciences.

[8]  Xueting Liu,et al.  Nivetetracyclates A and B: novel compounds isolated from Streptomyces niveus. , 2013, Organic letters.

[9]  Gerard D. Wright,et al.  Bacterial inactivation of the anticancer drug doxorubicin. , 2012, Chemistry & biology.

[10]  Changsheng Zhang,et al.  Δ(11,12) double bond formation in tirandamycin biosynthesis is atypically catalyzed by TrdE, a glycoside hydrolase family enzyme. , 2012, Journal of the American Chemical Society.

[11]  T. Oh,et al.  Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cell. , 2011, Bioorganic & medicinal chemistry.

[12]  Changsheng Zhang,et al.  Cloning and characterization of the biosynthetic gene cluster of the bacterial RNA polymerase inhibitor tirandamycin from marine-derived Streptomyces sp. SCSIO1666. , 2011, Biochemical and biophysical research communications.

[13]  G. Schneider,et al.  Aclacinomycin oxidoreductase (AknOx) from the biosynthetic pathway of the antibiotic aclacinomycin is an unusual flavoenzyme with a dual active site , 2007, Proceedings of the National Academy of Sciences.

[14]  G. Challis,et al.  PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Hoffmann,et al.  The new cytotoxic antibiotic cytorhodin X, an unusual anthracyclinone-9 alpha-glycoside. , 1992, The Journal of antibiotics.

[16]  T. Takeuchi,et al.  Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262. , 1991, The Journal of antibiotics.

[17]  H. Naganawa,et al.  Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730. , 1991, The Journal of antibiotics.

[18]  T. Takeuchi,et al.  Structure-sensitivity relationship of anthracycline antibiotics to C7-reduction by redox enzymes. , 1991, The Japanese journal of antibiotics.

[19]  H. Shibai,et al.  Differentiation inducing activity of anthracycline compounds in friend leukemia cells , 1986 .

[20]  H. Shibai,et al.  Production and Isolation of Cosmomycins A, B, C and D: New Differentiation Inducers of Friend Cell F5-5 , 1985 .

[21]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[22]  T. Koch,et al.  Spectroscopic observation of the tautomer of 7-deoxydaunomycinone from elimination of daunosamine from daunomycin hydroquinone , 1983 .

[23]  B. Schlegel,et al.  New anthracycline antibiotics produced by interspecific recombinants of streptomycetes. III. Isolation and structure of iremycin. , 1980, The Journal of antibiotics.

[24]  J. Mcgovren,et al.  Mammalian and microbial cell-free conversion of anthracycline antibiotics and analogs. , 1979, The Journal of antibiotics.

[25]  P. Wiley,et al.  Reductive microbial conversion of anthracycline antibiotics. , 1976, Biochemistry.

[26]  K. Chater,et al.  Lambda red-mediated genetic manipulation of antibiotic-producing Streptomyces. , 2004, Advances in applied microbiology.

[27]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[28]  L. Gille,et al.  Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. , 1997, Free radical biology & medicine.

[29]  T. Takeuchi,et al.  Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5. , 1993, The Journal of antibiotics.

[30]  H. Shibai,et al.  Cosmomycin D, a New Anthracycline Antibiotic , 1985 .